Vicente, EC, Pease, S, Imran, N, Gandhi, K, Ait-Tihuaty, M, Turkoz, I, Coteur, G, Gary, C, Choudhry, Z, Ramchandran, S, Vissing, J. Assessment of patient-reported outcomes from the phase 3 vivacity-MG3 study of nipocalimab in gMG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Villaverde, R, Gomez-Ballesteros, R, Reyes, V, Armangue, T, Querol, L, Gutierrez-Gutierrez, G, Sotoca, J, Ares, A, Salas, E, Abos, PD, Squaglia, A, Maurino, J, Cortes-Vicente, E. Herding-like behaviour in myasthenia gravis treatment decisions: exploring underlying mechanisms. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Lewis, RA, Suresh, N, Mazzeo, A, Allen, JA, Querol, L, Hussain, YM, Gwathmey, KG, Guptill, JT, Istas, G, Van Hoorick, B, Mole, T, Kuwabara, S, Basta, I, van Door, PA. SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: SELECTED SECONDARY OUTCOMES FROM THE ADHERE TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. EFFICACY OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: PHASE 2 SUBGROUP ANALYSES. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Falzone, Y, Querol, L, Lewis, R, Hartung, HP, van Doorn, P, Lin, J, Donnie, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, R. SAFETY AND EFFICACY OF RILIPRUBART IN CIDP 76-WEEK PHASE 2 TRIAL RESULTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

De Lorenzo, A, Moretti, GS, Bertini, A, De Lorenzo, A, Vidiella, RC, Falzone, YM, Fortanier, E, Gendre, T, Gentile, F, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mandia, D, Marion, M, Mira, V, Peric, S, Querol, L, Rajabally, Y, Sevilla, T, Tomaselli, PJ, Tozza, S, Bosca, M, Brouwer, M, Cocco, A, Cousyn, L, De Santis, T, Gonzalez, F, Lukic, MJ, Mistry, N, Maranzano, A, Morena, E, Nakano, FN, Saura, GO, Sechi, E, Ticozzi, N, Troisi, S, Tsokkos, T, Aymeric, W, Pisciotta, C, Orazio, EN, Pareyson, D, Doneddu, PE. CHAT-GPT-4O IN DIAGNOSIS AND MANAGEMENT OF REAL-LIFE POLYNEUROPATHY CASES: COMPARATIVE ANALYSIS WITH NEUROLOGISTS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Gallo, C, Doneddu, PE, Collet-Vidiella, R, Cocito, D, Manganelli, F, Falzone, Y, Pinter, GL, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Dalla Bella, E, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. EFFECT OF RITUXIMAB ON NEUROFILAMENT IN CIDP: DATA FROM THE CIDPRIT RANDOMIZED CONTROLLED TRIAL. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Allen, JA, Door, PAV, Benedetti, L, Basta, I, Dysgaard, T, Eggers, C, Guptill, JT, Gwathmey, KG, Hewamadduma, C, Hofman, E, Hussain, YM, Kuwabara, S, Le Masson, G, Leypoldt, F, Lin, J, Lipowska, M, Lowe, M, Pinter, GL, Querol, L, Simu, MA, Chang, TN, Tse, A, Ulrichts, P, Van Hoorick, B, Yamasaki, R, Lewis, RA. EFFICACY AND SAFETY OF SUBCUTANEOUS EFGARTIGIMOD PH20 IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: ADHERE/ADHERE plus TRIALS. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30DOI:. PMID:. IF:3.200(Q2/4D).

Storm, CS, Kia, DA, Almramhi, MM, Bandres-Ciga, S, Finan, C, Hingorani, AD, Wood, NW, Clarimón, J., Dols-Icardo O., Kulisevsky J., Marín J., Pagonabarraga J., Lynch, Timothy L.. Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome. Nature Communications. 2021; 12(1)DOI:10.1038/s41467-021-26280-1. PMID:34930919. IF:17.694(Q1/1D).

Blauwendraat, C, Iwaki, H, Makarious, MB, Bandres-Ciga, S, Leonard, HL, Grenn, FP, Lake, J, Krohn, L, Tan, M, Kim, JJ, Gibbs, JR, Hernandez, DG, Ruskey, JA, Pihlstrom, L, Toft, M, van Hilten, JJ, Marinus, J, Schulte, C, Brockmann, K, Sharma, M, Siitonen, A, Majamaa, K, Eerola-Rautio, J, Tienari, PJ, Grosset, DG, Lesage, S, Corvol, JC, Brice, A, Wood, N, Hardy, J, Gan-Or, Z, Heutink, P, Gasser, T, Morris, HR, Noyce, AJ, Nalls, MA, Singleton, AB, Clarimón J., Dols-Icardo, O, Kulisevsky J., Pagonabarraga, J, Int Parkinsons Dis Genomics Consor. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease. ANNALS OF NEUROLOGY. 2021; 90(1)DOI:10.1002/ana.26090. PMID:33901317. IF:11.274(Q1/1D).

Aibar-Durán JÁ, Villalba Martínez G, Freixer-Palau B, Araus-Galdós E, Morollón Sanchez-Mateos N, Belvis Nieto R, Revuelta Rizo M, Molet Teixeido J, García Sánchez C, de Quintana Schmidt C, Muñoz Hernandez F, Rodríguez Rodríguez R. Long-Term Results of Cortical Motor Stimulation for Neuropathic Peripheral and Central Pain: Real-World Evidence From Two Independent Centers.. Neurosurgery. 2024; 94(1)DOI:10.1227/neu.0000000000002638. PMID:37638720. IF:3.900(Q1/1D).

Kulisevsky J, Esquivel A, Freire-Álvarez E, Gómez-Esteban JC, Legarda-Ramírez I, Mata-Álvarez-Santullano M. SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.. REVISTA DE NEUROLOGIA. 2023; 77(s02)DOI:10.33588/rn.77s02.2023217. PMID:37752685. IF:0.800(Q4/9D).

Sampedro F. The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 234DOI:10.1016/j.clineuro.2023.107990. PMID:37806052. IF:1.800(Q2/5D).

Pérez-González, R, Vázquez-Oliver, A, Rivas-Asensio, E, Campolongo, A, Pons-Pons, G, Martínez-Horta, S, Pagonabarraga, J, Pascual-Sedano, B, Kulisevsky, J. Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood. PARKINSONISM & RELATED DISORDERS. 2026; 144DOI:10.1016/j.parkreldis.2026.108208. PMID:41643584. IF:3.400(Q2/3D).

Puig-Davi, A, Moreu-Valls, A, Aracil-Bolaños, I, Fernandez-Cocaño, A, Rodríguez-Antigüedad, J, Kulisevsky, G, Horta-Barba, A, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Effects of immersive virtual reality and adaptive cognitive training on cognition and function in parkinson's disease mild cognitive impairment: a randomized clinical trial. Scientific Reports. 2026; 16(1)DOI:10.1038/s41598-025-31833-1. PMID:41582160. IF:3.900(Q1/2D).

Bernardi, E, López-Lombardía, O, Olmedo-Saura, G, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2026; 27(2)DOI:10.3390/ijms27020881. PMID:41596528. IF:4.900(Q1/3D).

Ferreira, JJ, Stocchi, F, Antonini, A, Rascol, O, Ebersbach, G, Kulisevsky, J, Fonseca, MM, Ramos, D, Rocha, JF, Brigas, HC, Holenz, J, Poewe, W. Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1715748. PMID:41473225. IF:2.800(Q2/5D).

Camacho-Meño, L, Labandeira, CM, Bravo, SB, Torres, MV, Bejr-Kasem, H, Molina-Crespo, A, Atienza, M, Lanciego, JL, Cantero, JL, Kulisevsky, J, Labandeira-Garcia, JL, Rodriguez-Perez, AI. Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients. npj Parkinsons Disease. 2025; 12(1)DOI:10.1038/s41531-025-01230-6. PMID:41366251. IF:8.200(Q1/1D).

Kulisevsky, J, García-Ruíz, P, Outeiro, TF, Gurevich, T, Klivènyi, P, Van Laar, T, Milanov, I, Pirker, W, Popescu, BO, Toft, M, Szász, JA. Pharmacogenetics in advanced Parkinson's disease. JOURNAL OF NEURAL TRANSMISSION. 2025; 132(11)DOI:10.1007/s00702-025-03057-0. PMID:41222708. IF:4.000(Q1/2D).

Garcia-Forn, M, Castany-Pladevall, C, Creus-Muncunill, J, Golbano, A, Escaramís, G, Pérez-Pérez, J, Balantzategi, U, Hernan-Godoy, M, Brito, V, Kulisevsky, J, Martí, E, Pérez-Navarro, E. Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients. Neurotherapeutics. 2025; 22(6)DOI:10.1016/j.neurot.2025.e00716. PMID:40774881. IF:6.900(Q1/1D).